Journal of Hematology and Oncology Research
Open Access
Drivers and Barriers to Medication Adherence in Patients with Chronic Myeloid Leukaemia: A Qualitative Study
Nov 2017 DOI 10.14302/issn.2372-6601.jhor-17-1761
Gitte Lee MortensenCorresponding author
With the introduction of tyrosine kinase inhibitors (TKI), patients with chronic myeloid leukemia (CML) have obtained survival rates close to normal. It may appear paradoxical, then, that medication adherence is suboptimal in some health care settings. As the first of its kind, this study aimed to e…